PAHC - Phibro Animal Health Corp. - Ordinary Shares - Class A
IEX Last Trade
21.07
-0.400 -1.898%
Share volume: 286,970
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$21.47
-0.40
-1.86%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2022-08-24 | 2022-11-09 | 2023-02-08 | 2023-05-03 | 2023-08-30 | 2023-11-08 | 2024-02-07 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 931.699 M | 948.378 M | 961.833 M | 965.432 M | 971.397 M | 964.523 M | 972.708 M | 979.035 M | |
| Current Assets | 566.232 M | 570.080 M | 581.689 M | 585.483 M | 585.723 M | 584.424 M | 586.586 M | 597.180 M | |
| Inventories | 259.158 M | 280.842 M | 288.984 M | 292.833 M | 277.570 M | 279.154 M | 286.680 M | 282.289 M | |
| Other Current Assets | 49.289 M | 60.230 M | 62.453 M | 62.672 M | 63.393 M | 64.889 M | 56.786 M | 55.056 M | |
| Short Term Investments | 49.289 M | 60.230 M | 62.453 M | 62.672 M | 63.393 M | 64.889 M | 56.786 M | 55.056 M | |
| Total Receivables | 166.537 M | 142.728 M | 151.830 M | 152.740 M | 163.479 M | 149.228 M | 150.627 M | 161.087 M | |
| Current Cash | 91.248 M | 86.280 M | 78.422 M | 77.238 M | 81.281 M | 91.153 M | 92.493 M | 98.748 M | |
| Total Non-current Assets | 365.467 M | 378.298 M | 380.144 M | 379.949 M | 385.674 M | 380.099 M | 386.122 M | 381.855 M | |
| Property Plant Equipment | 165.490 M | 179.393 M | 186.122 M | 188.939 M | 195.568 M | 193.359 M | 200.839 M | 202.061 M | |
| Other Assets | 29.015 M | 32.259 M | 28.531 M | 26.596 M | 26.281 M | 24.094 M | 15.815 M | 14.053 M | |
| Intangible Assets | 63.861 M | 61.133 M | 59.064 M | 56.901 M | 54.987 M | 52.184 M | 50.962 M | 48.239 M | |
| Goodwill | 53.226 M | 53.209 M | 53.228 M | 53.243 M | 53.274 M | 53.251 M | 54.683 M | 54.644 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 931.699 M | 948.378 M | 961.833 M | 965.432 M | 971.397 M | 964.523 M | 972.708 M | 979.035 M | |
| Total liabilities | 669.257 M | 685.622 M | 693.463 M | 693.104 M | 688.888 M | 691.454 M | 701.905 M | 708.941 M | |
| Total current liabilities | 190.832 M | 172.499 M | 167.569 M | 165.308 M | 176.000 M | 172.355 M | 187.735 M | 189.072 M | |
| Accounts Payable | 95.596 M | 88.379 M | 80.487 M | 75.768 M | 73.853 M | 77.216 M | 86.410 M | 82.613 M | |
| Other liabilities | 28.992 M | 31.098 M | 35.320 M | 31.720 M | 31.270 M | 31.360 M | 34.124 M | 33.799 M | |
| Current long term debt | 15.000 M | 15.420 M | 15.420 M | 15.420 M | 22.295 M | 24.150 M | 26.045 M | 29.811 M | |
| Long term debt | 417.925 M | 451.738 M | 460.806 M | 466.016 M | 452.541 M | 458.717 M | 448.853 M | 456.008 M | |
| Other liabilities | 28.992 M | 31.098 M | 35.320 M | 31.720 M | 31.270 M | 31.360 M | 34.124 M | 33.799 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 262.442 M | 262.756 M | 268.370 M | 272.328 M | 282.509 M | 273.069 M | 270.803 M | 270.094 M | |
| Common stock | 40.504 M | 40.504 M | 40.504 M | 40.504 M | 40.504 M | 40.504 M | 40.504 M | 40.504 M | |
| Retained earnings | 247.748 M | 246.744 M | 249.094 M | 254.275 M | 260.912 M | 248.037 M | 244.450 M | 247.995 M |